Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMIT metformin trial in impaired glucose tolerance after TIA or minor ischemic stroke
2006-005772-41Phase 2Active
- Sponsor
- investigator-driven research: Erasmus MC, Neurovascular Section
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of metformin in prediabetes (2 arms), sponsored by investigator-driven research: Erasmus MC, Neurovascular Section. Primary endpoints: Tolerability of metformin treatment, Safety of metformin treatment and 1 more. Started Oct 2006; status: active.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2006-005772-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005772-41.